Aerie Pharmaceuticals reported $8.08M in Trade Creditors for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Adamas Pharmaceuticals ADMS:US 4.21M 1.74M
Aerie Pharmaceuticals AERI:US $ 8.08M 0.64M
Alimera Sciences ALIM:US $ 7.44M 0.35M
Amarin AMRN:US $ 72.42M 68.84M
Bluebird Bio BLUE:US $ 21.67M 17.63M
Coherus Biosciences CHRS:US $ 45.71M 31.14M
Endo International Ordinary Shares ENDP:US $ 111.04M 7.2M
Flexion Therapeutics FLXN:US $ 7.49M 2.02M
Gw Pharmaceuticals GWPH:US $ 16.67M 5.2M
Horizon Pharma HZNP:US $ 50.72M 1.22M
Insmed INSM:US $ 23.53M 7.55M
JAZZ PHA JAZZ:US $ 63.82M 1.01M
Mirati Therapeutics MRTX:US $ 42.92M 19.05M
Novartis NOVN:VX 4.66B 146M
Pacira Pharmaceuticals PCRX:US $ 7.9M 4.28M
Regeneron Pharmaceuticals REGN:US $ 427M 49M
Revance Therapeutics RVNC:US $ 8.04M 138K
Teva Pharmaceutical Industries TEVA:US $ 1514M 37M
Valeant Pharmaceuticals VRX:CN $ 455M 13M
Zoetis ZTS:US $ 387M 18M
Zogenix ZGNX:US $ 12.11M 1.28M